The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is linked with cardiovascular disease
There are some concerns around use of the GLP-1 agents, such as weight regain after stopping treatment, the potential for a loss of skeletal muscle mass, long-term adherence, and the limited evidence that exists for long-term safety, Moiz et al say
Acute Pancreatitis Inform patients of the potential risk for acute pancreatitis and its symptoms: severe abdominal pain that may radiate to the back, and which may or may not be accompanied by nausea or vomiting
AMPK, AMP-activated protein kinase alpha
Copper peptides used in skincare are generally regulated as cosmetic ingredients rather than as medicines, and no GHK-Cu product is FDA-approved to treat, cure, or prevent any disease